ABEO News

Latest breaking news and updates for ABEO stock.

Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences

(NASDAQ:ABEO) CLEVELAND, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that members of its management team will participate in upcoming investor confer...

Investor relations

1 day ago

Abeona Therapeutics® Reports Second Quarter 2025 Financial Results and Corporate Updates

- Received FDA approval for ZEVASKYN™ (prademagene zamikeracel), the first and only autologous cell-based gene therapy for the treatment of wounds in adult and pediatric patients with recessive dys...

How might this FDA approval influence analyst sentiment and target price revisions for ABEO? What guidance is management providing for Q3 and full‑year 2025 earnings after the FDA approval? Are there any outstanding regulatory or litigation risks that could affect the commercial rollout of ZEVASKYN™?

Earnings

16 days ago